,Dopamine,Serotonin,Acetylcholine,Cannabinoid receptor,Auditory brain regions,Visual brain regions,Frontal cortex,Limbic system,Thalamus,Cholinergic structures,Default Mode Network (DMN),Dorsal Attention Network (DAN),Ventral Attention Network (VAN),Frontotemporal connectivity,Thalamocortical circuits,Misattribution of internal stimuli,Self-monitoring deficits,Reality monitoring,Attentional control,Bottom-up and top-down processing,Norepinephrine,Inflammation,Trophic Factors,Synucleinopathy,Gut Microbiota,Basal Ganglia,Amygdala,Hippocampus,Hypothalamus,Prefrontal Cortex,Orbitofrontal Cortex,Anterior Cingulate Cortex (ACC),Medial Frontal Cortex,Dorsolateral Prefrontal Cortex,Locus Coeruleus (LC),Raphe Nuclei,Limbic Circuits,Corticostriatal Circuits,Striatal-Thalmic-Prefrontal Circuits,Frontemporal Regions,Gut-Brain Axis,Emotional Regulation,Reward System,Cognitive Impairment,Stress Response,Dopaminergic Neuron Loss,Serotonergic Cell Loss,Noradrenergic Dysfunction,GABA and Glutamate,Corticolimbic Circuits,Connections between emotional and motor control areas,Social Anxiety,"""Reactive"" Anxiety",Anxious Personality,Impulse Control Disorders (ICDs),Cholinergic and Noradrenergic Systems,Medial Frontal Cortex (ACC and Orbitofrontal cortex),Striatum,Other regions,Cortico-basal ganglia circuits,Mesocorticolimbic Pathway,Reward Circuitry,White Matter Tracts,Motivation and Goal-Directed Behavior,Executive Functions,Self-activation,Emotional Processing,Glutamate,Ventral Striatum,Fronto-striatal Disconnection,Fronto-Striatal Network,Impaired Executive Function,Loss of Inhibitory Control,Negative Reinforcement,GABA,Melatonin,Orexin/Hypocretin,Alpha-synuclein,Substantia Nigra,Brainstem,Forebrain,Ascending Reticular Activating System (ARAS),Circadian System,REM sleep circuitry,Sleep architecture,Motor control,REM sleep without atonia (RWA),Cognitive Dysfunction,Depression and anxiety,Adenosine,Cholinergic neurons,Histamine,Hypocretin (Orexin),Basal Forebrain,Caudate,Ascending Arousal System,Circadian Rhythm Regulation,Cognitive Decline,Awareness of Sleepiness,Impact on Daily Functioning
Hallucinations and psychosis,"Increased dopaminergic transmission, particularly in the mesocorticolimbic pathway, may contribute to the onset and exacerbation of hallucinations ; Both dopamine deficiency and excess dopamine from medication may alter dopamine-related synaptic plasticity","Elevated levels of 5-HT2A serotonergic receptor binding in the ventral visual pathway, medial orbitofrontal cortex, and insula have been linked to visual hallucinations; Levodopa can act as a partial agonist at 5-HT2A receptors, which may contribute to the development of Parkinson’s disease psychosis (PDP)","Cholinergic innervation deficits, caused by the degeneration of basal forebrain cholinergic nuclei, may affect the processing of complex visual stimuli, contributing to the development of visual hallucinations","Alterations in the cannabinoid system have been observed, with decreased CB1 receptor availability in the substantia nigra but increased density in other areas ","Auditory hallucinations are thought to involve the primary auditory cortex (superior temporal gyrus), secondary auditory association areas, and language processing areas such as Wernicke’s and Broca’s areas; Reduced grey matter volume in the superior temporal gyrus is a common finding in patients experiencing auditory hallucinations; Increased activity in language areas and the primary auditory cortex has been observed during active hallucination; Altered connectivity among temporal, prefrontal, and anterior cingulate regions has been reported","Visual hallucinations are associated with alterations in both the dorsal and ventral visual pathways; The dorsal stream is involved in processing spatial location and motion; Hypometabolism and reduced activation in regions such as the superior parietal lobe, precuneus, and middle temporal gyrus may contribute to visual hallucinations; The ventral stream is involved in object recognition; Hypometabolism in the fusiform gyrus, inferior temporal gyrus, and parahippocampal gyrus may play a role in visual hallucinations; Atrophy in the cuneus, middle occipital gyrus, and lingual gyrus are commonly reported","Altered activity and atrophy in the frontal cortex, including the prefrontal cortex and anterior cingulate cortex, have been associated with hallucinations; These regions are involved in attention, self-monitoring, and the distinction between internally and externally generated stimuli","The limbic system, including the hippocampus, amygdala, and cingulate gyrus, plays a role in the emotional and memory aspects of hallucinations ","The thalamus is a crucial hub for information flow between distributed cortical networks; Thalamic hypometabolism, atrophy, and disconnection from posterior brain areas are linked to aberrant disinhibition of the default mode network (DMN), which may contribute to hallucinations","Degeneration of cholinergic structures, such as the pedunculopontine nucleus (PPN) and substantia innominata (SI), a part of the basal forebrain, have been associated with hallucinations","The DMN is involved in internal mentation tasks, such as introspection and mental imagery; Aberrant coupling of the DMN with visual networks is a common finding in individuals experiencing hallucinations, suggesting that internally generated mental imagery may intrude on visual perception","The DAN is responsible for goal-directed and sustained attention; Dysfunction in the DAN, leading to a failure in recruiting this network during ambiguous visual input, may result in the incorporation of perceptual errors into the visual processing stream","Enhanced signaling through the VAN, especially through overactivation of the amygdala, can increase susceptibility to interference by irrelevant stimuli ",Reduced functional connectivity between the frontal and temporal lobes has been linked to the misattribution of internally generated speech or sensory stimuli as external,Disconnection between the thalamus and posterior brain areas is thought to lead to aberrant disinhibition of the DMN,A prominent theory suggests that hallucinations arise from a misattribution of internally generated speech or sensory stimuli as coming from an external source ,"Hallucinating individuals may have deficits in self-monitoring, which is the ability to distinguish between self-generated and externally generated stimuli; This may result from a lack of connectivity between brain regions that initiate an action and those that perceive its sensory consequences","Hallucinations may be linked to difficulties in reality monitoring, where the individual has trouble distinguishing between internally generated information and external reality",Reduced attentional control over interference may play a role in the emergence of minor hallucinations,"Hallucinations may arise from a failure of bottom-up processing of sensory information, leading to an over-reliance on top-down processing, which results in misinterpretations of the environment",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Depressed mood,There is a progressive dopaminergic neuronal death in the nigrostriatal pathway in PD; Dysfunction occurs in the presynaptic terminals of the mesolimbic dopaminergic system; There is decreased dopamine transporter (DAT) binding and reduced dopaminergic metabolism; An imbalance of D3 versus D2 receptors is also observed,"There are decreased levels of serotonin (5-HT) in the striatum and other areas ; There is increased serotonin transporter (SERT) binding in some areas, possibly reflecting greater serotonin clearance, and decreased SERT in the limbic system; There are also lower levels of 5-hydroxy indole acetic acid (5-HIAA), a 5-HT metabolite, in PD patients with depression; 5-HT reuptake sites are abnormally diminished in PD patients with or without depression, and serotonergic neurons in the raphe nucleus degrade more severely in PD patients with depression",Cortical cholinergic loss is related to depression in PD; There are decreases in binding to α4β2-nicotinic receptors,,,,,,Decreased dopamine levels in the thalamus can affect motor function and emotion; Noradrenergic dysfunction in the thalamus has been related to PD depression and anxiety; The limbic thalamus is also part of the areas that show altered connectivity in DPD,,,,,,,,,,,,"Noradrenergic deficits are seen in prodromal and idiopathic PD; There is reduced norepinephrine transporter binding in the locus coeruleus (LC), which is the principal noradrenergic nucleus in the CNS; The accumulation of α-synuclein in LC results in LC neuronal loss and degeneration, which may result in reduced levels of norepinephrine (NE) in several brain areas","Increased levels of pro-inflammatory molecules are implicated; There are elevated levels of soluble interleukin-2 receptor (sIL-2R), tumor necrosis factor-alpha (TNFα), and C-reactive protein (CRP); Inflammation may reduce 5-HT levels via an indoleamine-2, 3-dioxygenase (IDO) mediated reduction in tryptophan","There are disruptions in neurotrophic factors, particularly decreased levels of brain-derived neurotrophic factor (BDNF); BDNF is involved in neuronal plasticity, and its decrease may contribute to depression","There is increased synucleinopathy in the substantia nigra, ventral tegmental area, and nucleus accumbens in patients with Lewy body disorders and depression; Alpha-synuclein becomes misfolded and clumps together and is cytotoxic",A leaky gut and related inflammatory responses have been linked to depression in PD; Alterations in gut microbiota may contribute to the severity of depressive symptoms,"The basal ganglia, including the striatum, substantia nigra, and subthalamic nucleus, are key regions affected in PD; The mesolimbic dopamine system, which connects the ventral tegmental area (VTA) to the nucleus accumbens (NAc), is disrupted; Dopamine neuron degeneration in the substantia nigra pars compacta (SNpc) affects motor and emotional processing; The ventral striatum is involved in reward and emotions, and changes there may contribute to depressive symptoms; Lower dopamine levels in the caudate nucleus of the striatum are observed in PD patients with depression compared to those without",Hypermetabolism in the amygdala has been noted; Reduced connectivity between the amygdala and frontoparietal regions is also observed in depressed patients; The amygdala is also impacted by increased SERT binding and lower levels of 5HT1A receptors,Reduced hippocampal volume is related to depression; There is also lower binding of 5HT1A receptors in the hippocampus,Increased SERT binding is observed,Dysfunction in the prefrontal cortex is linked to depression in PD,Lower grey matter density and hypometabolism are seen in this region; A neural circuit between the VTA and orbitofrontal cortex may play a role in developing depression,Hypometabolism and lower grey matter density are observed; Decreased SERT in the subgenual ACC is related to depression; There is also decreased binding to nicotinic receptors in the ACC,Hypometabolism is present,This region is targeted by TMS to alleviate depression,"As mentioned above, the principal noradrenergic nucleus in the CNS, undergoes degeneration and has reduced NE, and its function is related to depression in PD",These nuclei are key for serotonergic transmission. Increased SERT binding and decreased levels of 5-HT are observed in this region,"There is widespread dysfunction of the limbic network, including altered connectivity",These circuits are affected by structural and functional changes,Dysfunction in these circuits is implicated in PD depression,"Altered functional connectivity between the striatum, thalamus, and these regions is observed in depressed patients; Functional connectivity in the posterior cingulate cortex is increased in patients with PD depression; Reduced connectivity in cortical-subcortical limbic circuities and increased connectivity between specific limbic areas (amygdala, limbic thalamus, temporal cortex) have been identified in DPD","The microbiota-gut-brain signaling is implicated in non-motor symptoms, including depressive disorders in PD","The disruption of limbic circuits and neurotransmitter systems interferes with emotional regulation, resulting in depressive symptoms","The mesolimbic dopamine reward circuit is disrupted in early stages of PD ; Dopamine deficiency generates dysregulations in the dopamine-mediated reward system, leading to disorders like anhedonia ","Depression and cognitive impairment share many common risk factors; Depression can predict a decline in cognitive performance, and cognitive decline is also related to depression; Poorer multi-domain cognitive performance predicts increased incidence of depression and anxiety in early PD",The mesocortical and noradrenergic stress-response systems are dysfunctional ; Dysregulation of the HPA axis and increased cortisol levels can exacerbate depression and motor functions in PD; Chronic stress may increase the vulnerability of dopaminergic neurons to degeneration,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Anxious mood,,,,,,,,,,,,,,,,,,,,,,,,,,"The basal ganglia has connections to brain areas that regulate emotion, anxiety, and fear, but its exact role in mediating these responses is not clear",The amygdala and associated limbic structures play a crucial role in the expression of emotions like fear and anxiety; Perturbation of dopaminergic input to the amygdala is implicated in abnormal emotional expression in PD patients; Studies have shown increased amygdala metabolism in depressed PD patients ,This area receives noradrenergic input from the locus coeruleus and is involved in integrating responses to anxiety,,Dopamine depletion in the prefrontal cortex has been linked to anxiety-like behavior; Studies have shown increased neural activity in prefrontal regions in depressed PD patients; There is also evidence of decreased functional connectivity between the prefrontal and limbic structures in depressed PD patients,,,,,"This region is involved in noradrenergic transmission, and cell loss in this area can contribute to anxiety in PD; Lower dopamine/noradrenaline transporter binding in this area is associated with increased anxiety",,,,,,,,,,,The cardinal motor symptoms of PD result from the degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc); This dopamine depletion is also linked to anxiety; Anxiety symptoms may be more sensitive to dopamine depletion than motor symptoms,"Serotonergic neurons in the raphe nuclei, which provide input to corticolimbic structures involved in anxiety, are lost prior to nigrostriatal dopaminergic degeneration; Abnormalities in the action of serotonin (5-HT) are linked to anxiety","Noradrenergic projections from the locus coeruleus, which innervate areas involved in integrating anxiety responses, are impacted by cell loss in PD ; Changes in the expression of noradrenaline (NA) receptors and transporters may lead to or worsen anxiety",Abnormalities in the gamma-aminobutyric acid (GABA) and glutamate neurotransmitter systems have been shown in patients with PD and may be involved in the development of anxiety; Drugs that modulate these systems have shown potential to treat anxiety ,"Serotonergic neurons project to these circuits involved in anxious states, suggesting that abnormalities in serotonin action in these networks contribute to anxiety","The connections between brain areas controlling emotions and those controlling posture may contribute to the manifestation of anxiety in PD, and postural control may be affected by anxiety",Patients with PD may experience social anxiety due to fear of negative public evaluation; Social phobia is associated with suppression of dopaminergic transmission ,Anxiety may be a reaction to the psychosocial stress of having a chronic disease like PD and the associated disability,"Some studies suggest that individuals with an anxious personality may have an increased risk of developing PD, implying shared biological mechanisms between anxiety and PD","ICDs, which are characterized by a failure to resist an impulse, are a group of anxiogenic conditions that have received special attention in PD; These disorders involve the ventral striatum and may be influenced by dopamine agonists, particularly those with relative selectivity for D3 receptors ",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Apathy,"Apathy is frequently associated with a dysfunction in the dopaminergic system, which plays a crucial role in motivation and reward-based behaviors; Reduced dopamine release and transmission in the mesocorticolimbic pathway is linked to motivational apathy, which is a type of apathy characterized by a lack of emotional resonance; This pathway includes the ventral tegmental area (VTA), nucleus accumbens (NAc), and prefrontal cortex ; Dopamine modulates reward-based behaviors through striatal projections ; Approach behaviors are mediated by the direct pathway with D1 receptors (D1Rs), while avoidance behaviors use the indirect pathway with D2 receptors (D2Rs) ; Partial dopamine denervation in the substantia nigra pars compacta (SNc) impairs motivational preparatory processes, resembling some forms of apathy ; Apathy can result from a severe dopamine depletion state in the mesocorticolimbic system","Serotonergic denervation within the mesocorticolimbic pathway also contributes to motivational apathy; Serotonergic circuits may compensate for DA denervation, and combined DA and serotonergic denervation may underlie motivational apathy",,,,,,,"The medial thalamus is implicated in apathy, with lesions in this area leading to reduced spontaneous activity",,,,,,,,,,,,,,,,,,,,,"The PFC plays a crucial role in goal-directed behavior, executive functions, and emotional processing",,,,"The DLPFC is involved in executive functions, such as planning and organizing; Dysfunction here can lead to cognitive apathy, which is related to deficits in planning and cognitive control",,,,,,,,,,,,,,,,,,,,,,"Cholinergic and noradrenergic systems are also implicated, especially in cognitive apathy; Cholinergic denervation can impair attention and executive functions, while noradrenergic deficits contribute to apathy through reduced precision of expected outcomes","These areas are consistently linked to apathy across various pathologies; Dysfunction in the ACC and OFC contributes to deficits in motivation, emotional processing and decision-making; Specifically, the dorsal anterior cingulate cortex (dACC) plays a role in initiating and sustaining actions; The orbitofrontal cortex (OFC) is involved in reward processing and emotional responses; The medial orbitofrontal cortex (mOFC) is linked to hedonic impact or ""liking"" ; Hypometabolism in the orbitofrontal cortex and anterior cingulate is associated with apathy","The striatum, which includes the caudate and putamen, is a critical part of the basal ganglia and is involved in motor control, reward processing, and motivation; The ventral striatum (VS) is particularly important in reward anticipation and processing, and it is part of the mesolimbic pathway; Reduced activity or connectivity in the VS is linked to apathy; The caudate nucleus is involved in executive functions","Other regions that are implicated in apathy include the posterior cingulate cortex, putamen, inferior temporal cortex, and insula","These involve the prefrontal cortex, basal ganglia (including the striatum, globus pallidus, and substantia nigra), and thalamus; Three main corticostriatal circuits are identified: sensorimotor, associative, and limbic; These circuits are involved in motor control, cognitive processes, and emotional regulation, respectively; Disruptions within these networks, especially involving connections between the prefrontal cortex and limbic system, can lead to apathy","Dysfunction in this pathway is strongly linked to motivational apathy; It involves the VTA, NAc, and prefrontal cortex","Apathy is associated with disruption in the reward circuitry, which involves the VTA, nucleus accumbens, orbitofrontal cortex, and other regions; Apathy may result from a failure to generate options for behavior, impaired selection between options, and reduced ability to learn from outcomes","White matter tracts, such as the anterior cingulum, play a role in the development of apathy; Damage to these tracts disrupts communication between brain regions","Sensitivity to stimuli - deficits in responding to internal or external stimuli; Reward processing - Diminished ability to attach motivational value to stimuli, and reduced anticipation or experience of pleasure; Decision making - impaired ability to select actions based on their potential costs and benefits; Initiation and execution of actions - difficulty in starting and carrying out actions; Effort-based decision making (EBDM) - Apathy may result from a reduced sensitivity to rewards or an increased sensitivity to effort costs. This can disrupt the initiation, vigor, and persistence of actions","Deficits in executive functions, such as planning, organizing, and sustaining attention, contribute to cognitive apathy","Apathy can result from the inability to activate oneself, or to initiate mental processing without external stimulation","Apathy involves emotional blunting or indifference, which is a key differentiator from depression",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
Dopamine Dysregulation Syndrome,"Repeated exposure to dopaminergic drugs can cause neuroadaptations in the nucleus accumbens, resulting in long-lasting changes in dopaminergic and GABAergic neurotransmission; This leads to a state of hypersensitivity to the rewarding effects of these drugs ; The dopamine system becomes hyper-responsive, attributing increased ""incentive salience"" to the dopaminergic drugs; This means that the drugs themselves are attributed with attractive properties, leading to an intense ""wanting"" or craving, separate from the ""liking"" or pleasure derived from the drugs",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"The orbitofrontal cortex plays a critical role in impulse control, risk-taking, and the ability to delay immediate gratification for future rewards; Dysfunction in this area can contribute to the loss of control over drug-taking and other repetitive and impulsive behaviors",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"DDS involves dysfunction within the neural system that is involved in reward signaling; Dopamine replacement therapy, while aiming to restore normal dopamine levels in motor pathways, can abnormally stimulate the mesocorticolimbic system, leading to addictive disorders; This network is also implicated in the development of impulse control disorders ",,,,,,"Neuroadaptations in cortico-striatal glutamatergic projections, which occur with repeated exposure to salient stimuli, enhance motivation for reward-seeking and craving","Studies have shown that PD patients with DDS have increased levodopa-induced dopamine release in the ventral striatum compared to matched patients without DDS; This increased dopamine release correlates with self-reported compulsive drug ""wanting"" but not ""liking""","A disconnection in the fronto-striatal pathway has been observed in PD patients with pathological gambling, which is often associated with DDS","This network, which includes the orbitofrontal cortex, is crucial for goal-directed behavior and impulse control; Alterations in the connectivity within this network are thought to contribute to the development of DDS ","While not a primary feature of DDS, impaired executive functions, particularly in decision-making and learning from negative feedback, may contribute to the development of compulsive behaviors; Some studies suggest that difficulties with selective and sustained attention may be present in DDS patients, possibly due to higher medication intake",A relative imbalance between enhanced appetitive drive and reduced top-down inhibitory control from prefrontal cortical areas has been hypothesized to underlie the pathophysiology of ICDs in PD,Patients with DDS often report that their drug use is driven by a need to avoid unpleasant OFF symptoms; The negative experiences associated with end-of-dose wearing off and the presence of a chronic depressive state may enhance the incentive value of dopaminergic drugs,,,,,,,,,,,,,,,,,,,,,,,,,,
Sleep problems,"Dopamine plays a significant role in the regulation of sleep and circadian homeostasis; In PD, the degeneration of dopaminergic neurons, particularly in the substantia nigra, disrupts the normal sleep-wake cycle; The loss of dopamine affects the balance of neurotransmitters that regulate sleep, such as GABA, acetylcholine, and glutamate",,,,,,,,,,,,,,,,,,,,,,,,,,This region of the brain is linked to the emotional content of dreams and may be implicated in REM sleep behavior disorder,,"The suprachiasmatic nuclei (SCN) in the hypothalamus is the location of the endogenous oscillator, or ""master clock"" of the circadian system",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"GABAergic neurons in the forebrain preoptic nucleus play a role in the transition from wakefulness to non-REM sleep; An imbalance between GABA and glutamate, especially in brainstem-subcortical circuits, can contribute to REM sleep behavior disorder (RBD)","The circadian rhythm of melatonin can be reduced or phase-advanced in PD patients, which can lead to poor sleep","Although primarily related to daytime sleepiness, the loss of hypocretin neurons in the hypothalamus may also impact overall sleep regulation","Accumulation of alpha-synuclein is a key feature of PD and may play a role in sleep disturbances, particularly RBD; It may also cause endoplasmic reticulum (ER) stress and impact cellular ""quality control machinery"" leading to sleep problems",Degeneration of dopaminergic neurons in this area is a hallmark of PD and disrupts the sleep-wake cycle,"The brainstem contains several nuclei, such as the locus coeruleus, dorsal raphe nucleus, and pedunculopontine nucleus, which are involved in the regulation of sleep and wakefulness; Degeneration in these regions can lead to sleep disturbances ; The sublaterodorsal tegmental nucleus (SLD) in the pons is involved in the generation of REM sleep","The preoptic area (POA), particularly the ventrolateral preoptic nucleus (VLPO) and the median preoptic nucleus (MnPn), is important for promoting non-REM sleep; The basal forebrain is also involved in the sleep-wake cycle","This network includes various neurotransmitter systems that control wakefulness and arousal through projections to the thalamus and neocortex, and is affected in PD","The circadian system comprises the endogenous oscillator in the SCN, entrainment agents (zeitgebers), and pathways that couple the internal clock to physiological and behavioral rhythms; Dopamine plays a role in this system; Dysfunction of this system is implicated in poor sleep quality",The glutamatergic neurons in the sublaterodorsal tegmental nucleus and the subceruleus and magnocellularis nuclei in the brainstem are part of the network that controls REM sleep; Breakdown of this network is implicated in RBD,"PD affects both sleep macrostructure (sleep fragmentation, increased superficial sleep) and microstructure (disturbed sleep spindles and K-complexes); Sleep efficiency is reduced in PD",Nocturnal akinesia or hypokinesia can disrupt sleep and mimic symptoms of restless leg syndrome; Impaired turning ability in bed is also associated with sleep disturbances,"The loss of muscle atonia during REM sleep is a key feature of RBD, which is common in PD; The network that inhibits muscle movement during REM sleep breaks down in RBD, which can result in dream enactment",Cognitive impairment can lead to difficulty initiating or maintaining sleep,"Depression is common in PD and may contribute to sleep disturbances, particularly insomnia",,,,,,,,,,,
Daytime sleepiness,Dopaminergic areas are affected by neurodegeneration in PD; Dopaminergic medications can also contribute to somnolence,The serotonergic dorsal raphe nucleus is part of the ascending arousal system ,,,,,,,,,,,,,,,,,,,The noradrenergic locus coeruleus and dorsal motor nucleus of the vagus nerve are involved in arousal ,,,,,,,,"The lateral hypothalamus, which contains hypocretin cells, is involved in maintaining wakefulness; Hypocretin cell loss in PD can lead to sleep disorders",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"A ligand of the benzodiazepine allosteric site of GABAA receptors, eszopiclone, has been studied for insomnia in PD",,,,,"Neurodegeneration within the ascending arousal systems in the brainstem affects neurotransmission across several neuronal nuclei; The brainstem is crucial for regulating sleep and wakefulness, with specific nuclei, such as the locus coeruleus, dorsal raphe nucleus, and tuberomammillary nucleus, being affected by PD",,,,,,,,,,This neurotransmitter promotes non-REM sleep,Promote REM sleep in the laterodorsal tegmental and pedunculopontine tegmental nuclei,The histaminergic tuberomammillary nucleus is also involved in wakefulness ,Loss of hypocretin cells in the hypothalamus may contribute to EDS in PD; Reduced hypocretin levels have been found in the prefrontal cortex and lateral ventricle,"This area, part of the ascending arousal system, is also impacted in PD",Dopamine denervation in the caudate has been linked to EDS,"This network, involving the brainstem and other regions, is critical for maintaining wakefulness; Neurodegeneration in PD disrupts this system, leading to sleep disorders","Disruptions in the sleep-wake cycle can occur in PD due to the neurodegenerative process; Specifically, there is a loss of rhythmicity in circadian genes",EDS is associated with an increased risk of cognitive decline; Sleepiness itself can worsen cognitive function,Some PD patients may not be aware of their sleepiness; Dopamine agonists may also reduce awareness of falling asleep,"EDS significantly impairs daytime functioning and impacts the quality of life, and can lead to motor vehicle crashes"